Pepper-Spray-induced Respiratory Failure Treated With Extracorporeal Membrane Oxygenation

PEDIATRICS ◽  
1996 ◽  
Vol 98 (5) ◽  
pp. 961-963
Author(s):  
Deborah F. Billmire ◽  
Charles Vinocur ◽  
Maureen Ginda ◽  
Nancy B. Robinson ◽  
Howard Panitch ◽  
...  
Keyword(s):  
United States ◽  
Respiratory Failure ◽  
Extracorporeal Membrane Oxygenation ◽  
The United States ◽  
Accidental Exposure ◽  
Membrane Oxygenation ◽  
Self Defense ◽  
Lack Of Information ◽  
Life Threatening ◽  
Serious Injury

Self-defense sprays have been available to the general public since the 1970s. They are easily obtained and over 6 million spray units were sold in the United States in 1993 alone. The intent of these sprays is to cause skin and mucosal irritation without producing serious injury. We describe the accidental exposure to pepper-gas spray of an infant who experienced immediate life-threatening respiratory distress followed by progressive deterioration. Ultimately, he required extracorporeal membrane oxygenation (ECMO) for survival. The decision to place the infant on ECMO was made more difficult by the lack of information about potential reversibility with this rare toxic cause of respiratory failure.

Inflight use of extracorporeal membrane oxygenation for severe neonatal respiratory failure

Perfusion ◽  
1986 ◽  
Vol 1 (4) ◽  
pp. 281-287 ◽  
Author(s):  
J. Devn Cornish ◽  
Dale R Gerstmann ◽  
Martin J Begnaud ◽  
Donald M Null ◽  
Neil B Ackerman
Keyword(s):  
Respiratory Failure ◽  
Extracorporeal Membrane Oxygenation ◽  
The United States ◽  
Air Transport ◽  
Referral Centre ◽  
Therapeutic Measure ◽  
The Past ◽  
Membrane Oxygenation ◽  
Life Threatening ◽  
Ecmo Treatment

Extracorporeal membrane oxygenation (ECMO) is a heart-lung bypass technique which has been used over the past ten years to support some 300 neonates with life-threatening respiratory failure. It is estimated that, within the constraints of currently accepted treatment criteria, there are between 2,000 and 3,000 neonates born each year within the United States who require this extreme therapeutic measure. Unfortunately, since there are still relatively few medical centres in the country offering this type of support, it is frequently necessary to transport candidate neonates from the hospital of birth to a referral centre. This is generally a tenuous procedure since neonates who are sufficiently ill to require ECMO treatment are commonly poor transport risks. We report the first successful use of an ECMO system designed to be transported to the referring hospital, assembled, and used to support an infant on bypass for a controlled air transport back to the receiving medical centre. The potential for decreasing the morbidity and mortality of selected infants requiring ECMO support by the addition of this capability is discussed.

Neonatal Extracorporeal Membrane Oxygenation

PEDIATRICS ◽  
1988 ◽  
Vol 82 (2) ◽  
pp. 276-277
Author(s):  
STEVEN M. DONN
Keyword(s):  
United States ◽  
Respiratory Failure ◽  
Extracorporeal Membrane Oxygenation ◽  
The United States ◽  
Membrane Oxygenation ◽  
Widespread Acceptance ◽  
Long Term Follow Up ◽  
Ecmo Therapy

The number of centers providing extracorporeal membrane oxygenation (ECMO) therapy to newborns with intractable respiratory failure has grown dramatically. The ECMO registry now includes 37 institutions in the United States,1 and there may be additional centers offering ECMO but not participating in the registry. To date, more than 1,400 patients have been treated with ECMO with a survival rate exceeding 80%. Widespread acceptance of ECMO therapy has been accomplished despite a paucity of controlled clinical trials2 and without the benefit of long-term follow-up of survivors. Initial fervor about neonatal ECMO has stemmed from the excellent survival statistics cited by most of the earlier investigators.2-4

scholarly journals Extracorporeal Membrane Oxygenation for ARDS: National Trends in the United States 2008–2012

2016 ◽  
Vol 61 (10) ◽  
pp. 1293-1298 ◽  
Author(s):  
Bhupinder S Natt ◽  
Hem Desai ◽  
Nirmal Singh ◽  
Chithra Poongkunran ◽  
Sairam Parthasarathy ◽  
...  
Keyword(s):  
United States ◽  
Extracorporeal Membrane Oxygenation ◽  
The United States ◽  
Membrane Oxygenation ◽  
National Trends

Utilization patterns of extracorporeal membrane oxygenation in neonates in the United States 1997–2012

2017 ◽  
Vol 52 (10) ◽  
pp. 1681-1687 ◽  
Author(s):  
Ashley Y. Song ◽  
Hsuan-Hsiu Annie Chen ◽  
Rachel Chapman ◽  
Ameish Govindarajan ◽  
Jeffrey S. Upperman ◽  
...  
Keyword(s):  
United States ◽  
Extracorporeal Membrane Oxygenation ◽  
The United States ◽  
Membrane Oxygenation ◽  
Utilization Patterns

Three consecutive cases of fatal intraoperative intracardiac thrombosis associated with the initiation of venoarterial extracorporeal membrane oxygenation in the presence of aprotinin

Perfusion ◽  
2019 ◽  
Vol 34 (5) ◽  
pp. 417-421 ◽  
Author(s):  
Chris Oscier ◽  
Chinmay Patvardhan ◽  
Florian Falter ◽  
Will Tosh ◽  
John Dunning ◽  
...  
Keyword(s):  
United States ◽  
Cardiac Surgery ◽  
Extracorporeal Membrane Oxygenation ◽  
Hospital Mortality ◽  
Cardiogenic Shock ◽  
Bleeding Risk ◽  
The United States ◽  
Membrane Oxygenation ◽  
Venoarterial Extracorporeal Membrane Oxygenation ◽  
Intracardiac Thrombosis

Central venoarterial extracorporeal membrane oxygenation has been used since the 1970s to support patients with cardiogenic shock following cardiac surgery. Despite this, in-hospital mortality is still high, and although rare, thrombus within the cardiac chambers or within the extracorporeal membrane oxygenation circuit is often fatal. Aprotinin is an antifibrinolytic available in Europe and Canada, though not currently in the United States. Due to historical safety concerns, use of aprotinin is generally limited and is commonly reserved for patients with the highest bleeding risk. Given the limited availability of aprotinin over the last decade, it is not surprising to find a complete absence of literature describing the use of venoarterial extracorporeal membrane oxygenation in the presence of aprotinin. We present three consecutive cases of rapid fatal intraoperative intracardiac thrombosis associated with post-cardiotomy central venoarterial extracorporeal membrane oxygenation in patients receiving aprotinin.

scholarly journals Contemporary look at extracorporeal membrane oxygenation as a bridge to reoperative lung transplantation in the United States – a retrospective study

2020 ◽  
Vol 33 (8) ◽  
pp. 895-901 ◽  
Author(s):  
Jeremiah William Awori Hayanga ◽  
Heather K. Hayanga ◽  
James H. Fugett ◽  
Kelsey A. Musgrove ◽  
Ghulam Abbas ◽  
...  
Keyword(s):  
United States ◽  
Retrospective Study ◽  
Extracorporeal Membrane Oxygenation ◽  
Lung Transplantation ◽  
The United States ◽  
Membrane Oxygenation
Sign in / Sign up

Export Citation Format

Share Document